branded drugs – The Milli Chronicle

Monday, April 27, 2026

Latest:

Factual Version of a Story

Asia Latest News Top Stories

NewsDesk MC April 27, 2026April 27, 2026 $11.75 billion deal, biosimilars, branded drugs, corporate acquisition, dermatology, emerging markets, global healthcare, healthcare business, India pharma deal, Indian pharmaceutical industry, mergers and acquisitions, Mumbai, obesity drugs, oncology, Organon, pharma expansion, pharmaceutical acquisition, specialty medicines, Sun Pharma, U.S. drugmaker, Women’s Health

Sun Pharma Strikes $11.75 Billion Organon Deal in India’s Biggest Pharma Acquisition

Mumbai — Sun Pharmaceutical Industries will acquire U.S.-based drugmaker Organon & Co in an all-cash deal valued at about $11.75

Business Latest News World

NewsDesk MC September 27, 2025September 29, 2025 branded drugs, business updates Singapore, export exemptions, Gan Kim Yong, global trade news, international trade, pharma export growth, pharmaceutical industry news, semiconductor sector, Singapore economy, Singapore latest news, Singapore pharma companies, Singapore pharmaceutical exports, Singapore trade news, trade negotiations, trade talks, US commerce policy, US import duties, US tariffs, US-Singapore trade

Singapore Seeks Tariff Exemptions After U.S. Imposes 100% Duties on Branded Drugs

Singapore’s government is actively pressing the United States to grant exemptions from sweeping new 100% tariffs on branded pharmaceutical imports,